The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart procedure compared to the current standard of care.

Conditions

  • Left Ventricular Dysfunction
  • Coronary Artery Disease

Intervention

  • Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
  • IABP Intra-aortic balloon pump

Principal Investigator

  • Bharadwaj, Aditya

Sponsor

  • Abiomed Inc.

*The source of data for this particular study is "ClinicalTrials.gov" and was last updated on 05/16/2024. Loma Linda University does not make any warranties, expressed or implied, with respect to such data, and, furthermore, assumes no liability for any party's use, or the results of such use of the data.

Request Information

Complete the form below to contact the study team and receive more information about this trial.